Healthcare provider profile · identity verified

Sarah Colter, NP

Nurse Practitioner · ROCKFORD, MI · NPI 1366168494

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	373	113
Lisinopril	Lisinopril	236	74
Levothyroxine Sodium	Levothyroxine Sodium	222	75
Amlodipine Besylate	Amlodipine Besylate	158	51
Losartan Potassium	Losartan Potassium	131	45
Omeprazole	Omeprazole	122	42
Simvastatin	Simvastatin	114	39
Metformin Hcl Er	Metformin Hcl	104	27
Hydrochlorothiazide	Hydrochlorothiazide	101	35
Metoprolol Succinate	Metoprolol Succinate	101	35
Trazodone Hcl	Trazodone Hcl	91	32
Duloxetine Hcl	Duloxetine Hcl	86	28
Rosuvastatin Calcium	Rosuvastatin Calcium	77	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	76	27
Pantoprazole Sodium	Pantoprazole Sodium	72	26
Metformin Hcl	Metformin Hcl	66	19
Escitalopram Oxalate	Escitalopram Oxalate	60	18
Venlafaxine Hcl Er	Venlafaxine Hcl	58	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	57	24
Eliquis	Apixaban	55	14
Jardiance	Empagliflozin	55	suppressed
Sertraline Hcl	Sertraline Hcl	55	18
Meloxicam	Meloxicam	53	27
Montelukast Sodium	Montelukast Sodium	53	14
Metoprolol Tartrate	Metoprolol Tartrate	50	12
Bupropion Xl	Bupropion Hcl	48	17
Oxybutynin Chloride Er	Oxybutynin Chloride	45	15
Albuterol Sulfate Hfa	Albuterol Sulfate	43	23
Glipizide Er	Glipizide	42	12
Trulicity	Dulaglutide	39	suppressed
Alendronate Sodium	Alendronate Sodium	38	14
Tamsulosin Hcl	Tamsulosin Hcl	38	15
Gabapentin	Gabapentin	35	17
Pravastatin Sodium	Pravastatin Sodium	34	13
Tramadol Hcl	Tramadol Hcl	33	suppressed
Atenolol	Atenolol	32	suppressed
Januvia	Sitagliptin Phosphate	32	suppressed
Ezetimibe	Ezetimibe	31	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Potassium Chloride	Potassium Chloride	29	suppressed
Spironolactone	Spironolactone	29	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	28	suppressed
Furosemide	Furosemide	26	12
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	24	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Celecoxib	Celecoxib	21	suppressed
Famotidine	Famotidine	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Glipizide	Glipizide	19	suppressed
Ozempic	Semaglutide	19	suppressed
Baclofen	Baclofen	18	suppressed
Cephalexin	Cephalexin	18	13
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	11
Lovastatin	Lovastatin	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Ondansetron Odt	Ondansetron	17	13
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Fluticasone Propionate	Fluticasone Propionate	16	11
Hydrocortisone	Hydrocortisone	16	suppressed
Carvedilol	Carvedilol	15	suppressed
Clopidogrel	Clopidogrel Bisulfate	15	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	15	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Spiriva Respimat	Tiotropium Bromide	15	suppressed
Varenicline Tartrate	Varenicline Tartrate	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Naproxen	Naproxen	14	suppressed
Prednisone	Prednisone	14	12
Torsemide	Torsemide	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Allopurinol	Allopurinol	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Finasteride	Finasteride	12	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error